Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 6 studies | 83% ± 20% | |
retinal rod cell | 6 studies | 72% ± 19% | |
retinal bipolar neuron | 3 studies | 26% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 4 studies | 52% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 75% | 275.50 | 1990 / 2642 | 0% | 0 | 0 / 705 |
bladder | 5% | 1.67 | 1 / 21 | 0% | 0.02 | 2 / 504 |
prostate | 4% | 2.44 | 9 / 245 | 0% | 0 | 0 / 502 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
stomach | 3% | 1.58 | 10 / 359 | 0% | 0 | 0 / 286 |
esophagus | 2% | 0.98 | 24 / 1445 | 1% | 0.01 | 1 / 183 |
intestine | 2% | 0.95 | 16 / 966 | 0% | 0.00 | 1 / 527 |
eye | 0% | 0 | 0 / 0 | 1% | 0.07 | 1 / 80 |
breast | 1% | 0.75 | 5 / 459 | 0% | 0 | 0 / 1118 |
lung | 1% | 0.46 | 3 / 578 | 0% | 0.00 | 1 / 1155 |
uterus | 1% | 0.51 | 1 / 170 | 0% | 0 | 0 / 459 |
thymus | 0% | 0.33 | 3 / 653 | 0% | 0 | 0 / 605 |
skin | 0% | 1.06 | 8 / 1809 | 0% | 0 | 0 / 472 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.03 | 1 / 230 |
muscle | 0% | 0.26 | 3 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.10 | 2 / 861 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.10 | 2 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.01 | 1 / 901 |
blood vessel | 0% | 0.10 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0007601 | Biological process | visual perception |
GO_0010753 | Biological process | positive regulation of cGMP-mediated signaling |
GO_0007602 | Biological process | phototransduction |
GO_0031284 | Biological process | positive regulation of guanylate cyclase activity |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0097381 | Cellular component | photoreceptor disc membrane |
GO_0001917 | Cellular component | photoreceptor inner segment |
GO_0120199 | Cellular component | cone photoreceptor outer segment |
GO_0030249 | Molecular function | guanylate cyclase regulator activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008048 | Molecular function | calcium sensitive guanylate cyclase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GUCA1A |
Protein name | Guanylyl cyclase-activating protein 1 (GCAP 1) (Guanylate cyclase activator 1A) Guanylyl cyclase-activating protein 1 (Guanylate cyclase activator 1A) |
Synonyms | C6orf131 GCAP GUCA1 GCAP1 |
Description | FUNCTION: Stimulates retinal guanylyl cyclase when free calcium ions concentration is low and inhibits guanylyl cyclase when free calcium ions concentration is elevated . This Ca(2+)-sensitive regulation of retinal guanylyl cyclase is a key event in recovery of the dark state of rod photoreceptors following light exposure (By similarity). May be involved in cone photoreceptor light response and recovery of response in bright light (By similarity). . |
Accessions | A0A7I2V6E2 ENST00000679182.1 P43080 ENST00000372958.2 |